Your browser doesn't support javascript.
loading
Low body mass index and risk of mortality after mitral transcatheter edge-to-edge repair procedure: The "obesity paradox".
Carter-Storch, Rasmus; Veien, Karsten T; Mogensen, Nils Sofus Borg; Banke, Ann; Tofte-Hansen, Emil Ulrikkaholm; Ali, Mulham; Laursen, Kristian; Dahl, Jordi Sanchez.
Afiliação
  • Carter-Storch R; Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Veien KT; Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Mogensen NSB; Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Banke A; Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Tofte-Hansen EU; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Ali M; Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Laursen K; Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Dahl JS; Department of Cardiology, Odense University Hospital, Odense, Denmark.
Catheter Cardiovasc Interv ; 104(2): 401-407, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38819910
ABSTRACT

BACKGROUND:

Most patients undergoing the mitral transcatheter edge-to-edge repair (TEER) technique are elderly comorbid patients. Low body mass index (BMI) < 23 kg/m2 has been identified in other elderly populations as a risk factor, but has not been studied sufficiently in mitral TEER.

AIMS:

We aimed to study the impact of low BMI (23 kg/m2) on the outcome after mitral TEER.

METHODS:

Patients undergoing first-time TEER for mitral regurgitation at a single tertiary center were included, with the exclusion of patients with preprocedural hemodynamic instability or missing BMI. The primary endpoint was all-cause mortality. Secondary endpoints were long-term major bleeding or admission with heart failure.

RESULTS:

A total of 120 patients (mean age 76 ± 10 years, 76% men) were included in the study. Thirty-nine (31%) had low BMI. Patients with low BMI had a similar symptomatic benefit as patients with BMI ≥ 23 kg/m2 at 1 year regarding decrease in diuretics dose and decrease in New York Heart Association (NYHA) class (p > 0.05). In a multivariable Cox regression analysis, BMI as a continuous variable (hazard ratio [HR] 0.93 [95% confidence interval, CI 0.87-0.99], p = 0.03) and low BMI (HR 1.99 [95% CI 1.12-3.52], p = 0.02) were associated with the primary outcome. Low BMI was not significantly associated with major bleeding (subdistribution hazard ratio [SHR] 2.39 [95% CI 0.96-5.97], p = 0.06) or admission with heart failure (SHR 1.06 [95% CI 0.61-1.88], p = 0.83) during follow-up with univariable competing risk regression analysis.

CONCLUSION:

Low BMI is a risk factor for mortality after mitral valve TEER, confirming the presence of an "obesity paradox" in this population and should receive attention in patient selection.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cateterismo Cardíaco / Índice de Massa Corporal / Valva Mitral / Insuficiência da Valva Mitral Limite: Aged80 Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cateterismo Cardíaco / Índice de Massa Corporal / Valva Mitral / Insuficiência da Valva Mitral Limite: Aged80 Idioma: En Ano de publicação: 2024 Tipo de documento: Article